Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 5, Issue 1, Pages 63
Publisher
Springer Nature
Online
2012-10-11
DOI
10.1186/1756-8722-5-63
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer
- (2012) Qiu-Wan Wu et al. BMC CANCER
- VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium
- (2012) Tara Karnezis et al. CANCER CELL
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- A Phase I Dose-Escalation Study of Regorafenib (BAY 73-4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors
- (2012) K. Mross et al. CLINICAL CANCER RESEARCH
- Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling
- (2012) Rui Benedito et al. NATURE
- Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor
- (2011) W. Zheng et al. BLOOD
- DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
- (2011) J.-L. Li et al. CANCER RESEARCH
- Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Hepatocellular Carcinoma Cells
- (2011) Zeng Yong Yi et al. JOURNAL OF INVESTIGATIVE SURGERY
- VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
- (2011) Tuomas Tammela et al. NATURE CELL BIOLOGY
- Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
- (2011) J. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer
- (2010) Tian-Bao Wang et al. ANZ JOURNAL OF SURGERY
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre-Clinical Models
- (2010) DAI FUKUMURA et al. MICROCIRCULATION
- The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases
- (2010) R. S. Bhide et al. MOLECULAR CANCER THERAPEUTICS
- Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2010) Imke Albrecht et al. PLoS One
- Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors
- (2009) W. P. Tew et al. CLINICAL CANCER RESEARCH
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
- (2009) Y. Cao Science Signaling
- Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
- (2008) H. Huynh et al. CLINICAL CANCER RESEARCH
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
- (2008) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now